Skip to main content
. 2022 Dec 16;13(4):663–668. doi: 10.25259/JNRP-2022-6-19

Table 1:

Comparison of the UPDRS, EQ-5D-5L, TUG, FTSTS, gait velocity, and HADS scores between baseline and eight weeks and between the two groups by using generalized estimating equation adjusted for baseline scores.

Variables CBDEP group (n=19) P-Value Placebo group (n=17) P-Value Mean difference 95% CI P- Value
Baseline 8 weeks Baseline 8 weeks
Disease severity
Total UPDRS 55.9±26.14 46.5±25.40 0.004* 68.1±32.4 53.1±33.0 <0.001* 4.32 −3.68 to 13.32 0.290
UPDRS part I 8.58±6.04 5.47±3.53 <0.001* 13.88±7.62 8.52±8.01 <0.001* 1.1 −1.16 to 3.36 0.340
UPDRS part II 10±6.11 8.53±6.48 0.109 13±6.52 10.12±7.58 0.013* 1.01 −1.34 to 3.36 0.400
UPDRS part III 34.78±16.19 29.68±16.28 0.020* 38.29±19.30 31.41±17.81 0.005* 1.28 −3.86 to 6.41 0.626
UPDRS part IV 2.57±3.77 2.8±2.69 0.478 2.88±4.38 3±3.75 0.673 0.092 −0.61 to 0.79 0.796
Quality of life
EQ-5D-5L 0.77±0.27 0.87±0.30 0.006* 0.65±0.30 0.92±0.21 <0.001* −0.14 −0.23 to−0.04 0.004*
Functional performance
TUG (sec) 14.16±6.17 13.28±3.86 0.337 13.90±5.73 12.65±3.40 0.133 0.49 −1.08 to 2.06 0.537
FTSTS (sec) 13.95±4.29 13.66±3.54 0.490 15.10±7.41 13.91±5.38 0.096 0.63 −0.63 to 1.88 0.327
Gait velocity
(m/sec) 1.08±0.23 1.13±0.21 0.107 1.07±0.25 1.18±0.23 0.043* −0.06 −0.17 to 0.06 0.322
HADS score
Anxiety score 3.73±2.66 2.94±2.12 0.067 5.05±2.86 4.76±3.41 0.822 −0.82 −1.97 to 0.33 0.160
Depression score 3.157±2.75 2.05±1.71 0.015* 5.11±3.14 3.23±3.13 0.066 −0.37 −1.73 to 0.98 0.590

Data are presented as mean±standard deviation, *P<0.05, CBDEP, cannabidiol-enriched cannabis extraction product; CI, confidence interval; UPDRS, Unified Parkinson’s Disease Rating Scale; TUG, Timed Up and Go; FTSTS, Five Times Sit to Stand; HADS, Hospital Anxiety and Depression Scale.